These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24120978)

  • 1. Discovery of novel anxiolytic agents--the trials and tribulations of pre-clinical models of anxiety.
    Andrews NA; Papakosta M; Barnes NM
    Neurobiol Dis; 2014 Jan; 61():72-8. PubMed ID: 24120978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The failure of anxiolytic therapies in early clinical trials: what needs to be done.
    Stewart AM; Nguyen M; Poudel MK; Warnick JE; Echevarria DJ; Beaton EA; Song C; Kalueff AV
    Expert Opin Investig Drugs; 2015 Apr; 24(4):543-56. PubMed ID: 25727478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classical and novel approaches to the preclinical testing of anxiolytics: A critical evaluation.
    Haller J; Aliczki M; Gyimesine Pelczer K
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2318-30. PubMed ID: 22981935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of anxious disorders.
    Bourin M; Lambert O
    Hum Psychopharmacol; 2002 Dec; 17(8):383-400. PubMed ID: 12457374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of anxiety: are they suitable for predicting drug action in humans?
    Bourin M
    Pol J Pharmacol; 1997; 49(2-3):79-84. PubMed ID: 9437753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of new anxiolytic drugs (author's transl)].
    Boulenger JP
    Nouv Presse Med; 1982 May; 11(22):1687-94. PubMed ID: 6124934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental models of anxiety for drug discovery and brain research.
    Hart PC; Bergner CL; Smolinsky AN; Dufour BD; Egan RJ; Laporte JL; Kalueff AV
    Methods Mol Biol; 2010; 602():299-321. PubMed ID: 20012406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Models of Anxiety for Drug Discovery and Brain Research.
    Hart PC; Bergner CL; Smolinsky AN; Dufour BD; Egan RJ; LaPorte JL; Kalueff AV
    Methods Mol Biol; 2016; 1438():271-91. PubMed ID: 27150096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current animal models of anxiety, anxiety disorders, and anxiolytic drugs.
    Haller J; Alicki M
    Curr Opin Psychiatry; 2012 Jan; 25(1):59-64. PubMed ID: 22156938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of anxiety disorders: prevalence, biology, course, and treatment.
    Schatzberg AF
    J Clin Psychiatry; 1991 Jul; 52 Suppl():5-9. PubMed ID: 2071569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacology of the anxiety disorders.
    Ballenger JC
    Psychiatr Clin North Am; 1984 Dec; 7(4):757-71. PubMed ID: 6151647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent perspectives on the diagnosis and treatment of generalized anxiety disorder.
    Ninan PT
    Am J Manag Care; 2001 Sep; 7(11 Suppl):S367-76. PubMed ID: 11570027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anxiety and the mechanisms of action of anxiolytics].
    Marino A; Costa R
    Recenti Prog Med; 1993 Feb; 84(2):129-41. PubMed ID: 8096650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research in anxiety disorders: from the bench to the bedside.
    Garner M; Möhler H; Stein DJ; Mueggler T; Baldwin DS
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):381-90. PubMed ID: 19327970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety levels and related pharmacological drug treatment: a memorandum for the third millennium.
    Pasquini M; Berardelli I
    Ann Ist Super Sanita; 2009; 45(2):193-204. PubMed ID: 19636172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety disorders: dental implications.
    Little JW
    Gen Dent; 2003; 51(6):562-8; quiz 569. PubMed ID: 15055656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current and lifetime prevalence of obsessive compulsive disorders in eating disorders].
    Speranza M; Corcos M; Godart N; Jeammet P; Flament M
    Encephale; 2001; 27(6):541-50. PubMed ID: 11865561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.